Cargando…

The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials

C-C motif chemokine ligand 2 (CCL2) is a member of the monocyte chemokine protein family, which binds to its receptor CCR2 to induce monocyte infiltration and mediate inflammation. The CCL2/CCR2 signaling pathway participates in the transduction of neuroinflammatory information between all types of...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Huixia, Chen, Luna, Tang, Jing, Chen, Yi’ang, Wang, Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998625/
https://www.ncbi.nlm.nih.gov/pubmed/35408846
http://dx.doi.org/10.3390/ijms23073485
_version_ 1784684987959738368
author Geng, Huixia
Chen, Luna
Tang, Jing
Chen, Yi’ang
Wang, Lai
author_facet Geng, Huixia
Chen, Luna
Tang, Jing
Chen, Yi’ang
Wang, Lai
author_sort Geng, Huixia
collection PubMed
description C-C motif chemokine ligand 2 (CCL2) is a member of the monocyte chemokine protein family, which binds to its receptor CCR2 to induce monocyte infiltration and mediate inflammation. The CCL2/CCR2 signaling pathway participates in the transduction of neuroinflammatory information between all types of cells in the central nervous system. Animal studies and clinical trials have shown that CCL2/CCR2 mediate the pathological process of ischemic stroke, and a higher CCL2 level in serum is associated with a higher risk of any form of stroke. In the acute phase of cerebral ischemia-reperfusion, the expression of CCL2/CCR2 is increased in the ischemic penumbra, which promotes neuroinflammation and enhances brain injury. In the later phase, it participates in the migration of neuroblasts to the ischemic area and promotes the recovery of neurological function. CCL2/CCR2 gene knockout or activity inhibition can reduce the nerve inflammation and brain injury induced by cerebral ischemia-reperfusion, suggesting that the development of drugs regulating the activity of the CCL2/CCR2 signaling pathway could be used to prevent and treat the cell injury in the acute phase and promote the recovery of neurological function in the chronic phase in ischemic stroke patients.
format Online
Article
Text
id pubmed-8998625
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89986252022-04-12 The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials Geng, Huixia Chen, Luna Tang, Jing Chen, Yi’ang Wang, Lai Int J Mol Sci Review C-C motif chemokine ligand 2 (CCL2) is a member of the monocyte chemokine protein family, which binds to its receptor CCR2 to induce monocyte infiltration and mediate inflammation. The CCL2/CCR2 signaling pathway participates in the transduction of neuroinflammatory information between all types of cells in the central nervous system. Animal studies and clinical trials have shown that CCL2/CCR2 mediate the pathological process of ischemic stroke, and a higher CCL2 level in serum is associated with a higher risk of any form of stroke. In the acute phase of cerebral ischemia-reperfusion, the expression of CCL2/CCR2 is increased in the ischemic penumbra, which promotes neuroinflammation and enhances brain injury. In the later phase, it participates in the migration of neuroblasts to the ischemic area and promotes the recovery of neurological function. CCL2/CCR2 gene knockout or activity inhibition can reduce the nerve inflammation and brain injury induced by cerebral ischemia-reperfusion, suggesting that the development of drugs regulating the activity of the CCL2/CCR2 signaling pathway could be used to prevent and treat the cell injury in the acute phase and promote the recovery of neurological function in the chronic phase in ischemic stroke patients. MDPI 2022-03-23 /pmc/articles/PMC8998625/ /pubmed/35408846 http://dx.doi.org/10.3390/ijms23073485 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Geng, Huixia
Chen, Luna
Tang, Jing
Chen, Yi’ang
Wang, Lai
The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
title The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
title_full The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
title_fullStr The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
title_full_unstemmed The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
title_short The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials
title_sort role of ccl2/ccr2 axis in cerebral ischemia-reperfusion injury and treatment: from animal experiments to clinical trials
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998625/
https://www.ncbi.nlm.nih.gov/pubmed/35408846
http://dx.doi.org/10.3390/ijms23073485
work_keys_str_mv AT genghuixia theroleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT chenluna theroleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT tangjing theroleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT chenyiang theroleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT wanglai theroleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT genghuixia roleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT chenluna roleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT tangjing roleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT chenyiang roleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials
AT wanglai roleofccl2ccr2axisincerebralischemiareperfusioninjuryandtreatmentfromanimalexperimentstoclinicaltrials